62991-1513-4

Product NDC: 62991-1513
Requested package NDC: 62991-1513-4
11-digit product format: 629911513
Labeler code: 62991
Product ID: 62991-1513_75781859-c422-4337-8d0f-d8461105caa2
Type: BULK INGREDIENT
Nonproprietary name: Apomorphine Hydrochloride
Dosage form: POWDER
Marketing category: BULK INGREDIENT
Marketing start: 2010-10-27
Substance: APOMORPHINE HYDROCHLORIDE
Active strength: 1 g/g
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
unfinished package	package	62991-1513	62991-1513-4	UNFINISHED	Active or certified unfinished drug listing		2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 8 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 21:27 UTC · source 2025-12-05	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-08-26 23:59 UTC · source 2025-08-26	`1d862106b807…`	`00c93037cd84…`
2025-05-15 14:59 UTC · source 2025-05-14	`390b4c401c3f…`	`2c692c2daee3…`
2025-04-01 07:37 UTC · source 2025-03-31	`e30019b0c005…`	`a3f0b14938b7…`
2025-03-01 13:19 UTC · source 2025-02-28	`bbbc9f937eca…`	`946b9c97cf81…`
2025-02-27 05:24 UTC · source 2025-02-26	`f268b84574a6…`	`26285f5ac5df…`
2025-02-01 13:13 UTC · source 2025-01-31	`f764e8902f78…`	`92046438deef…`
2025-01-20 13:05 UTC · source 2025-01-17	`68b1e3bced9e…`	`98a755eb8bc6…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: No
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
APOMORPHINE HYDROCHLORIDE	1 g/g

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
62991-1513-1	GM - Gram	62991-1513	c2d38402-7b14-4efb-8105-ac3804cdbbd7	1	2013-03-03
62991-1513-2	GM - Gram	62991-1513	c1e1e291-1e95-47f9-b076-b4dbebff334c	1	2013-03-03
62991-1513-3	GM - Gram	62991-1513	ef63e51b-b36f-4ecf-a7f3-295403e6a301	1	2013-03-03
62991-1513-4	GM - Gram	62991-1513	537dff0f-b089-43c7-9b56-4456337f5bb7	1	2025-06-13

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
F39049Y068	APOMORPHINE HYDROCHLORIDE	41372-20-7	APOMORPHINE HYDROCHLORIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Status
62991-1513-4	62991151304	250 g in 1 JAR (62991-1513-4)	250 g	17-DEC-24	Current